Jazz Pharmaceuticals plc Contract with Customer, Liability, Noncurrent
Jazz Pharmaceuticals plc (JAZZ) had Contract with Customer, Liability, Noncurrent of $0 as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2023-03-01
- 2022-12-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2022-09-30: Contract with Customer, Liability, Noncurrent $116.00K.
- 2022-06-30: Contract with Customer, Liability, Noncurrent $231.00K.
- 2022-03-31: Contract with Customer, Liability, Noncurrent $347.00K.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-01 |
| 2022-09-30 | $116.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $231.00K 10-Q · filed 2022-08-03 |
| 2022-03-31 | $347.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | $463.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $986.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.51M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $1.85M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $2.31M 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.95M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $3.59M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $4.22M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $4.86M 10-K · filed 2021-02-23 |
| 2019-09-30 | $6.04M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $7.22M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $8.40M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $9.58M 10-K · filed 2020-02-25 |
| 2018-09-30 | $10.93M 10-Q · filed 2018-11-06 |
| 2018-01-01 | $14.99M 10-K · filed 2019-02-26 |
| 2017-12-31 | $16.11M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |